Back
Relay Therapeutics Stock Predictions
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
45
RLAY
Relay Therapeutics
Last Price:
5.79
Seasonality Move:
2.51%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeRelay Therapeutics Stock Forecast
- Over the next 52 weeks, Relay Therapeutics has on average historically fallen by 33.9% based on the past 4 years of stock performance.
- Relay Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Relay Therapeutics Stock Undervalued?
The current Relay Therapeutics [RLAY] share price is $5.81. The Score for RLAY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - RLAY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Relay Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Relay Therapeutics has on average historically fallen by 33.9% based on the past 4 years of stock performance.
Relay Therapeutics Stock Rating
Sell
45
Relay Therapeutics (RLAY)
is a Sell
Is Relay Therapeutics overpriced?
- Relay Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Relay Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
relaytx.com
52-Week Data
52-Week High:
12.14
52-Week Low:
5.60
Prediction Charts
Market Cap:
972.5M
Price in USD:
5.81
Volume:
1.39M
Beta:
1.68
Technical Analysis
SMA50:
6.75
SMA100:
7.05
SMA200:
7.46
52-Wk Change:
-24.64%
Stock Predictions
-
Is Relay Therapeutics stock public?
Yes, Relay Therapeutics is a publicly traded company. -
What is the Relay Therapeutics stock quote today?
The Relay Therapeutics stock price is 5.81 USD today. -
How to buy Relay Therapeutics stock online?
You can buy Relay Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-25 | 6.22 | 6.02 | 6.38 | 6.00 |
| Oct-28 | 6.06 | 6.03 | 6.17 | 5.93 |
| Oct-29 | 6.00 | 5.89 | 6.15 | 5.77 |
| Oct-30 | 5.85 | 5.71 | 6.09 | 5.70 |
| Oct-31 | 5.71 | 5.64 | 5.76 | 5.60 |
| Nov-1 | 5.69 | 5.84 | 6.00 | 5.63 |
| Nov-4 | 5.78 | 5.84 | 6.04 | 5.65 |
| Nov-5 | 5.78 | 5.95 | 6.00 | 5.66 |
| Nov-6 | 6.30 | 6.25 | 6.50 | 6.00 |
| Nov-7 | 6.33 | 6.14 | 6.48 | 5.96 |
| Nov-8 | 6.15 | 6.20 | 6.31 | 6.06 |
| Nov-11 | 6.32 | 6.16 | 6.39 | 6.10 |
| Nov-12 | 6.07 | 5.94 | 6.18 | 5.91 |
| Nov-13 | 6.00 | 5.81 | 6.10 | 5.81 |
Relay Therapeutics Earnings
Relay Therapeutics Earnings Report: Per Share Relay Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Relay Therapeutics Forecast Revenue Growth
Relay Therapeutics Stock Analysis: Historical quarterly revenues per share for Relay Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.02 per share.
* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.